Abad A - Search Results

1

Molecular staging of non-small cell lung cancer according to K-ras genotypes.

Rosell R, Monzó M, Pifarré A, Ariza A, Sánchez JJ, Moreno I, Maurel J, López MP, Abad A, de Anta JM. Rosell R, et al. Among authors: abad a. Clin Cancer Res. 1996 Jun;2(6):1083-6. Clin Cancer Res. 1996. PMID: 9816271

2

A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer.

Rosell R, Carles J, Ariza A, Moreno I, Ribelles N, Solano V, Pellicer I, Barnadas A, Abad A. Rosell R, et al. Among authors: abad a. Cancer. 1991 May 15;67(10):2448-53. doi: 10.1002/1097-0142(19910515)67:10<2448::aid-cncr2820671009>3.0.co;2-2. Cancer. 1991. PMID: 1707745 Clinical Trial.

3

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.

Carles J, Rosell R, Ariza A, Pellicer I, Sanchez JJ, Fernandez-Vasalo G, Abad A, Barnadas A. Carles J, et al. Among authors: abad a. Lung Cancer. 1993 Dec;10(3-4):209-19. doi: 10.1016/0169-5002(93)90181-v. Lung Cancer. 1993. PMID: 7521264

4

K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.

Li S, Rosell R, Urban A, Font A, Ariza A, Armengol P, Abad A, Navas JJ, Monzo M. Li S, et al. Among authors: abad a. Lung Cancer. 1994 Jul;11(1-2):19-27. doi: 10.1016/0169-5002(94)90279-8. Lung Cancer. 1994. PMID: 8081702

5

Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.

Sánchez-Céspedes M, Rosell R, Pifarré A, López-Cabrerizo MP, Barnadas A, Sánchez JJ, Lorenzo JC, Abad A, Monzó M, Navas-Palacios JJ. Sánchez-Céspedes M, et al. Among authors: abad a. Clin Cancer Res. 1997 Jul;3(7):1229-35. Clin Cancer Res. 1997. PMID: 9815804

6

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

Monzó M, Rosell R, Felip E, Astudillo J, Sánchez JJ, Maestre J, Martín C, Font A, Barnadas A, Abad A. Monzó M, et al. Among authors: abad a. J Clin Oncol. 1999 Jul;17(7):2100-4. doi: 10.1200/JCO.1999.17.7.2100. J Clin Oncol. 1999. PMID: 10561264

7

Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer.

Font A, Abad A, Monzó M, Sanchez JJ, Guillot M, Manzano JL, Piñol M, Ojanguren I, Rosell R. Font A, et al. Among authors: abad a. Dis Colon Rectum. 2001 Apr;44(4):549-57. doi: 10.1007/BF02234328. Dis Colon Rectum. 2001. PMID: 11330582

8

Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer.

Rosell R, Carles J, Abad A, Jimeno JM, Moreno I, Barnadas A, Ribelles N, Haboubi N. Rosell R, et al. Among authors: abad a. Invest New Drugs. 1992 Jul;10(2):123-8. doi: 10.1007/BF00873130. Invest New Drugs. 1992. PMID: 1323550 Clinical Trial.

9

Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer.

Rosell R, Carles J, Abad A, Ribelles N, Barnadas A, Benavides A, Martin M. Rosell R, et al. Among authors: abad a. Invest New Drugs. 1992 Aug;10(3):171-5. doi: 10.1007/BF00877242. Invest New Drugs. 1992. PMID: 1330970 Clinical Trial.

10

Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.

Martínez-López E, Abad A, Font A, Monzó M, Ojanguren I, Pifarré A, Sánchez JJ, Martín C, Rosell R. Martínez-López E, et al. Among authors: abad a. Gastroenterology. 1998 Jun;114(6):1180-7. doi: 10.1016/s0016-5085(98)70423-8. Gastroenterology. 1998. PMID: 9609754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters